E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/14/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Response Biomedical arranges C$2 million unit offering

By Sheri Kasprzak

New York, Dec. 14 - Response Biomedical Corp. said it has negotiated a non-brokered private placement for C$2 million.

The company plans to sell up to 4 million units at C$0.50 each.

The units include one share and one half-share warrant. The whole warrants are exercisable at C$0.70 each for two years.

Proceeds will be used for infrastructure, development and commercialization programs.

Vancouver, B.C.-based Response develops diagnostic tests.

Issuer:Response Biomedical Corp.
Issue:Units of one share and one half-share warrant
Amount:C$2 million (maximum)
Units:4 million (maximum)
Price:C$0.50
Warrants:One half-share warrant per unit
Warrant expiration:Two years
Warrant strike price:C$0.70
Pricing date:Dec. 14
Stock price:C$0.62 at close Dec. 14

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.